Abstract:Objective To study the expression levels of microRNA-138 (miR-138) and Runt-related transcription factor 3 (RUNX3) in peripheral blood of children with cough variant asthma (CVA) and their regulatory effects on Th1/Th2 balance. Methods Sixty-five children with CVA (CVA group) and 30 healthy children (control group) were enrolled. Peripheral venous blood samples were collected for both groups, and CD4+ T cells were isolated and cultured. Enzyme-linked immunosorbent assay was used to measure the levels of interferon (IFN)-γ, interleukin (IL)-2, IL-4, IL-5, and IL-13 that were secreted by CD4+ T cells. Flow cytometry was used to determine the percentages of Th1 and Th2 cells. Quantitative real-time PCR was used to measure the level of RUNX3 mRNA in CD4+ T cells and the level of miR-138 in peripheral blood. Western blot was used to determine the protein expression of RUNX3 in CD4+ T cells. The dual-luciferase reporter assay was used to determine the targeting effects of miR-138 and RUNX3. The RUNX3-mimic plasmid was transfected into CD4+ T cells, and the effects on the levels of IFN-γ, IL-2, IL-4, IL-5, and IL-13 and the percentages of Th1 and Th2 cells were measured. Results Compared with the control group, the CVA group showed significantly decreased levels of IFN-γ and IL-2 from CD4+ T cells, significantly increased levels of IL-4, IL-5, and IL-13 from CD4+ T cells, significantly decreased Th1 cell percentage and Th1/Th2 ratio, and a significantly increased Th2 cell percentage (P<0.05). The CVA group showed significantly lower relative expression levels of RUNX3 mRNA and protein in CD4+ T cells in peripheral blood than the control group (P<0.001). The relative expression level of miR-138 was significantly higher in the CVA group than in the control group (P<0.001). MiR-138 could target the expression of RUNX3. Upregulating the expression of RUNX3 in CD4+ T cells induced significantly increased levels of IFN-γ and IL-2, significantly decreased levels of IL-4, IL-5, and IL-13, significantly increased Th1 cell percentage and Th1/Th2 ratio, and a significantly decreased Th2 cell percentage (P<0.05). Conclusions MiR-138 regulates Th1/Th2 balance by targeting RUNX3 in children with CVA, providing a new direction for the treatment of CVA.
WANG Zhi-Gang,SHEN Gai-Qing,HUANG Yu-Huan. Regulatory effects of miR-138 and RUNX3 on Th1/Th2 balance in peripheral blood of children with cough variant asthma[J]. CJCP, 2021, 23(10): 1044-1049.
Bui TT, Piao CH, Kim SM, et al. Citrus tachibana leaves ethanol extract alleviates airway inflammation by the modulation of Th1/Th2 imbalance via inhibiting NF-κB signaling and histamine secretion in a mouse model of allergic asthma[J]. J Med Food, 2017, 20(7): 676-684. PMID: 28598706. DOI: 10.1089/jmf.2016.3853.
Keyhanmanesh R, Rahbarghazi R, Aslani MR, et al. Systemic delivery of mesenchymal stem cells condition media in repeated doses acts as magic bullets in restoring IFN-γ/IL-4 balance in asthmatic rats[J]. Life Sci, 2018, 212: 30-36. PMID: 30268855. DOI: 10.1016/j.lfs.2018.09.049.
Song Q, Shang J, Zhang CF, et al. Transcription factor RUNX3 promotes CD8+ T cell recruitment by CCL3 and CCL20 in lung adenocarcinoma immune microenvironment[J]. J Cell Biochem, 2020, 121(5-6): 3208-3220. PMID: 31898342. DOI: 10.1002/jcb.29587.
Men S, Yu YY, Zhang YH, et al. Methylation landscape of RUNX3 promoter region as a predictive marker for Th1/Th2 imbalance in bronchiolitis[J]. Med Sci Monit, 2019, 25: 7795-7807. PMID: 31622282. PMCID: PMC6820333. DOI: 10.12659/MSM.917196.
Matthews NC, Pfeffer PE, Mann EH, et al. Urban particulate matter-activated human dendritic cells induce the expansion of potent inflammatory Th1, Th2, and Th17 effector cells[J]. Am J Respir Cell Mol Biol, 2016, 54(2): 250-262. PMID: 26196219. PMCID: PMC4821044. DOI: 10.1165/rcmb.2015-0084OC.
Boskabady MH, Neamati A. Improvement of tracheal responsiveness and Th1/Th2 balance in a rat model of asthma, treated with portulaca oleracea[J]. Altern Ther Health Med, 2020, 26(6): 34-42. PMID: 31221948.
Lou LL, Tian MY, Chang JX, et al. MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7[J]. Biomed Pharmacother, 2020, 122: 109692. PMID: 31918268. DOI: 10.1016/j.biopha.2019.109692.
Zhao MZ, Li YP, Geng XR, et al. Expression level of miRNA-126 in serum exosomes of allergic asthma patients and lung tissues of asthmatic mice[J]. Curr Drug Metab, 2019, 20(10): 799-803. PMID: 31608839. DOI: 10.2174/1389200220666191011114452.
Fan LX, Wang XJ, Fan LL, et al. MicroRNA-145 influences the balance of Th1/Th2 via regulating RUNX3 in asthma patients[J]. Exp Lung Res, 2016, 42(8/10): 417-424. PMID: 27902892. DOI: 10.1080/01902148.2016.1256452.